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PA21, a strain of hepatitis A virus (HAV) recovered from a naturally infected captive owl monkey, is
indistinguishable from human HAV in polyclonal radioimmunoassays and cross-neutralization studies.
However, cDNA-RNA hybridization has suggested a significant difference at the genomic level between PA21
and a reference human virus, HM175. Further characterization of this unique HAV was undertaken in an
effort to determine the extent of genetic divergence from human HAV and its relation to the conserved antigenic
structure of the virus. The close similarity between PA21 and HM175 antigens was confirmed with an extended
panel of 18 neutralizing murine monoclonal antibodies: a reproducible difference in binding to the two viruses
was detected with only one antibody (B5-B3). The nucleotide sequence of the P1 region of the PA21 genome had
only 83.2% identity with HM175 virus, a difference approximately twice as great as that found between any two
human strains. Most nucleotide changes were in third base positions, and the amino acid sequences of the
capsid proteins were largely conserved. Amino acid replacements were clustered in the carboxy terminus of
VP1 and the amino-terminal regions of VP2 and VP1. These data indicate that PA21 virus represents a unique
genotype ofHAV and suggest the existence of an ecologically isolated niche for HAV among feral owl monkeys.
Hepatitis A virus (HAV) is a uniquely pathogenic hepato-
tropic picornavirus associated with acute viral hepatitis in
humans (17). Infection with HAV results in solid, lifelong
immunity, due in part to the absence of antigenic variation
among HAV isolates. Although direct comparisons are lim-
ited in number, human HAV strains are antigenically indis-
tinguishable from each other in solid-phase immunoassays
and neutralization tests employing either convalescent hu-
man polyclonal antibodies (18, 22) or murine monoclonal
antibodies (20). At the genomic level, the nucleotide se-
quences of these viruses have been estimated by T1 oligo-
nucleotide mapping to differ by only 1 to 4% (38), while a
comparison ofcDNA sequences derived from several human
HAV isolates indicates a 3 to 9% difference (5, 23, 25, 29, 32,
36; J. Ticehurst, personal communication). Thus, existing
human isolates of HAV represent a relatively homogeneous
collection of closely related viruses, having as a group
significantly less genetic diversity than that found among
isolates of single poliovirus serotypes (31).
Most previous studies have suggested that natural infec-
tion with HAV is confined to humans (8). However, a variety
of higher primate species, including chimpanzees (Pan tro-
glodytes) (13), marmosets (Saguinas sp.) (9), and owl mon-
keys (Aotus trivirgatus) (16), have been shown to be suscep-
tible to infection. Serologic evidence of infection with HAV
has been found among primates held in captivity (12), but
such infection generally has been considered to be of human
origin (8, 28). HAV appears capable of bidirectional trans-
mission between captive primates and their human keepers,
although the ultimate origin of virus causing hepatitis A in
animal handlers has never been entirely clear.
'In 1980, an HAV strain (PA21) was recovered from a feral
owl monkey shortly after its capture and admission to a
primate-holding facility in Panama (22). Serologic testing of
other owl monkeys demonstrated widespread infection with
HAV within the colony during the preceding years, with
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most wild-caught animals seroconverting within months of
capture. Virus recovered from infected monkeys was found
to be antigenically similar to human HAV by quantitative in
vitro neutralization assays (19), in cross protection studies,
and in preliminary studies with monoclonal antibodies (20).
Yet slot blot cDNA-RNA hybridization with probes derived
from human HAV suggested that the PA21 virus was distinct
from human HAV isolates (20). We now report the further
characterization of PA21 virus, undertaken in an effort to
determine the basis of its genetic diversity and how this
might relate to its highly conserved antigenic structure.
PA21 virus was adapted to growth in continuous green
monkey kidney cells (BS-C-1) as described previously (2).
The physical characteristics of PA21 particles produced in
BS-C-1 cells were compared with those of the prototype
human HAV strain, HM175, propagated in the same cell
line. Centrifugation of both PA21 and HM175 virus harvests
through linear rate-zonal sucrose gradients demonstrated
similar sedimentation profiles, with two major peaks of
antigen activity having sedimentation characteristics corre-
sponding to empty and full capsids (Fig. 1) (21, 34). The
PA21 antigen was distributed almost equally between the
two particle types, while approximately threefold more
HM175 antigen was associated with complete virions than
with empty capsids. This difference in the distribution of
antigen was constant for multiple purifications of both viral
strains. Fractions recovered from these gradients were blot-
ted onto nitrocellulose and hybridized with the pHAVCH119-
1 probe (representing nucleotides 158 to 843 of the HM175
genome). The resulting hybridization signal was strongest
with fractions containing complete virus particles, but
weaker hybridization signals were found with fractions tail-
ing into the empty-capsid region of the gradient (Fig. 1). In
both virus-containing gradients, there was a suggestion of a
discrete population of particles yielding positive hybridiza-
tion signals in fractions immediately preceding the empty-
capsid peak (fractions 18 and 19). Thus, with the exception
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FIG. 1. HAV antigen profile of HM175 (top) or PA21 (bottom)
virus after centrifugation through 10 to 30% (wt/vol) sucrose gradi-
ents. Antigen (U) was detected by a radioimmunoassay, and the
refractive index was measured with an Abbe-type refractometer. A
sample of each fraction was blotted onto nitrocellulose and hybrid-
ized with a 32P-labeled pHAVCH119-1 cDNA probe. The relative
optical densities of the autoradiograms were determined by a laser
densitometer and plotted as blot intensity (+).
vests, the sedimentation characteristics of PA21 and HM175
viruses were identical, including the possibility of a subpop-
ulation of slowly sedimenting RNA-containing particles.
To more fully characterize the antigenic relatedness of the
PA21 and HM175 viruses, we measured the binding of each
of an expanded panel of 18 neutralizing murine monoclonal
antibodies to virus that had been captured on a solid-phase
support with polyclonal human antiserum (the sources of 13
of these antibodies have been described previously [30];
14-1-C29, H29-C26, H10-C29, H80-C25, and H7-C27 were
the generous gift of R. H. Decker, Abbott Laboratories,
North Chicago, Ill.). Previously described direct and indirect
radioimmunoassay methods were employed for this analy-
sis, which utilized quantities of sucrose-CsCl gradient (7)-
purified viruses that were roughly standardized according to
viral RNA content (30). In replicate experiments employing
an indirect immunoassay, reduced binding of monoclonal
antibodies to the simian virus strain was suggested only with
antibodies 10.09 and B5-B3 (82 and 78%, respectively; Fig.
2). Direct immunoassays, which compared the binding of
radiolabeled monoclonal antibodies to HM175 and PA21,
demonstrated markedly reduced binding (20 to 30%) of
B5-B3 antibody to PA21 and only questionably reduced
binding of 10.09 and 2D2 (Fig. 2). Thus, these studies
confirmed the reduced affinity of the B5-B3 antibody for
PA21 virus but failed to demonstrate conclusive differences
in the binding of the other 17 monoclonal antibodies. As
these antibodies are directed against immunodominant neu-
tralization epitopes of HAV (30), the results indicate a high
degree of conservation of the critical antigenic determinants
of these two HAV strains.
To compare the genomic RNAs of the viruses, standard-
ized quantities ofRNA extracted from CsCl-sucrose gradient
(7)-purified PA21 and HM175 viruses were electrophoresed
through a formaldehyde-agarose gel, transferred to nitrocel-
lulose paper, and hybridized with probe pHAVCH119-1 (Fig.
3, lanes A and B). The size distribution of virion RNA from
both virus strains was similar: most RNA was full-length,
migrating with a 7.5-kilobase standard. However, in addition
to a smear of shorter-length RNAs, discrete bands of subge-
nomic-size RNA were evident in both PA21 and HM175 RNA
preparations. When the blot was stripped and then rehybrid-
ized with a probe derived from the P1 genomic region of PA21
virus (pHAVCHD64, nucleotides 896 to 3661; see below) (Fig.
3, lanes C and D), full-length HM175 RNA failed to produce
a significant signal. The failure of the PA21 probe to hybridize
with full-length HM175 virus RNA confirmed the existence of
significant genetic divergence between these viruses and
indicated that previous hybridization results (20) were not
related to deletions in the PA21 genome. However, the
smaller PA21 RNA species evident after probing with the 5'
HM175 cDNA probe (pHAVcH119-1) were not seen after
probing with the P1 region PA21 probe, suggesting that these
subgenomic-length RNAs may represent virion RNA with
deletions in the P1 region, as suggested by Nuesch et al. (26).
When the blot was again stripped and rehybridized with a
probe derived from the 3' region of the HM175 genome
(pHAVCH12-1, which extends from nucleotides 6058 to 7463),
there was a much-reduced hybridization signal with PA21
RNA (Fig. 3, compare lanes E and F). However, subgenomic-
length RNA was again identified in the HM175 RNA lane.
These findings are thus consistent with the presence of minor
populations of particles containing genomes with substantial
deletions or truncations in both PA21 and HM175 virus
stocks.
An examination of RNA associated with more slowly
sedimenting particles (fractions 18 and 19 of the gradients
shown in Fig. 1) revealed RNA species similar to those
demonstrated in Fig. 3. No RNA was detected in the
empty-capsid fractions, while the more slowly sedimenting
RNA-containing particles were associated with full-length
and much lesser amounts of subgenomic-length RNA (re-
sults not shown).
The apparent genetic divergence of the P1 regions of PA21
and human HAV genomes in the face of high-level conser-
vation of the immunodominant neutralization epitopes
prompted the determination of the nucleotide sequence of
the simian virus. cDNA was synthesized from PA21 virus
RNA by the method of Gubler and Hoffman (14) and cloned
into the EcoRI site of pTZ18R after linker addition. Single-





FIG. 2. Binding of murine monoclonal antibodies to immobilized
PA21 viral antigen expressed as the mean percentage of the amount
of antibody bound to PA21 compared with HM175 antigens in
replicate assays. The results of all 18 monoclonal antibodies in an
indirect assay (X) and results of tests with four antibodies in a direct
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FIG. 3. Northern (RNA) blot analysis of RNA extracted from
HM175 (lanes A, C, and E) and PA21 (lanes B, D, and F) virions.
The blot was sequentially hybridized with three cDNA probes: lanes
A and B, 5' HM175 probe; lanes C and D, P1 PA21 probe; lanes E
and F, 3' HM175 probe. The marker was a 7.5-kilobase poly(A)
tailed RNA.
helper bacteriophage M13K07 and sequenced by the dide-
oxy-chain termination method of Sanger et al. (33). Overlap-
ping cDNA clones spanning part of the 5' noncoding region,
the complete P1 region, and the 5' portion of the P2 region of
PA21 virus were sequenced completely, and the derived
sequences were compared with known sequences of human
HAV strains. Additional sequence was obtained from the 3'
noncoding region and the 3' terminus of the P3 genomic
region of PA21 virus. Altogether the 5' noncoding, P2, P3,
and 3' noncoding regions were found to have 89.2, 79.6,
84.4, and 93.7% nucleotide identity, respectively, with re-
spect to the human HM175 virus (Table 1) (5). The G+C
content of PA21 RNA was found to be 39.5%, only slightly
higher than that of other HAV strains (5). The typical HAV
bias against the CG nucleotide pair was present (frequency
of use, 0.4%) (5).
The P1 region of PA21 genomic RNA was found to
comprise 2,373 nucleotides and to encode 791 amino acids.
The nucleotide identity between PA21 and sequenced human
HAV strains was approximately 83% in the capsid-encoding
region (Table 1). The region encoding VP1 (Fig. 4) demon-
strated the greatest divergence (78.4 to 81.3% identity with
six human HAV strains), while the VP3-encoding region, as
in comparisons of other picornaviruses, was the most con-
served (84.7 to 86.0% identity). The majority of the nucleo-
tide changes occurred in the third codon position (343 of 398,
in comparison with HM175), while differences present in the
first or second positions often did not lead to a change in the
amino acid. Thus, the amino acid sequence of the capsid
proteins is largely conserved between the simian and human
viruses.
Overall, the PA21 nucleotide sequence indicates that its
capsid differs at only 23 (HM175 and MBB) to 31 (HAS15)
amino acid residues (of 791) compared with the capsids of
human HAV strains (Table 2). Most of these changes (16 of
23) are conservative in nature. Although the nucleotide
changes are distributed randomly across the P1 region (ex-
cept for the region encoding the carboxy terminus of VP1, at
the 3' end of the P1 region), amino acid replacements are
clustered near the amino termini of VP2 and VP1 and the
carboxy terminus of VP1 (Fig. 5). Of the 31 carboxy-terminal
amino acids of VP1, 8 are different from those of HM175
virus. When the amino acid sequence was aligned with a
proposed tertiary structure of HAV capsid proteins (27), all
of the nonconservative amino acid changes were found to be
in surface loops and not in alpha helices or the beta pleated-
sheet backbone structure. Posttranslational cleavage sites
proposed by either Cohen et al. (5) or Diamond et al. (11) are
unchanged.
It is possible that the genetic divergence evident between
PA21 and the human HAV strains could reflect multiple
passages of the PA21 strain though an alternate (owl mon-
key) host within the primate colony in Panama (38), even if
PA21 was originally derived from humans. However, an
analysis of sequences derived from several HM175 variants
argues against this. The human HM175 strain has been
sequenced in its entirety three times: as a wild-type variant
passed three times in marmosets (wt HM175) (37), as a cell
culture-adapted variant passed a total of six times in mar-
mosets and then 16 times in cell culture (p16 HM175) (15),
and as another cell culture-adapted and attenuated variant
passed 35 times in cell culture after independent isolation
directly from human feces (p35 HM175) (4). The sequences
of these three HM175 variants, which are separated by three
to six passages in marmosets, differ only by two to three
nucleotides in the P1 region, making it difficult to contend
that passage of an originally human strain of HAV in owl
monkeys held in the primate colony could account for the
large number of nucleotide changes found in PA21 virus.
TABLE 1. Percent nucleotide identity between PA21 and human HAV isolates
% Nucleotide identity to:
Genomic region
HM175 LA MBB CR326 HAS15 MS1
5' noncoding (bases 456 to 734) 89.2 88.9 89.6 88.6 89.0
P1
VP4'a 92.8 94.2 89.9 92.8 92.8
VP2 83.0 82.7 83.0 82.4 83.5
VP3 84.8 85.5 86.0 85.2 84.7
VP' 81.3 80.0 80.3 80.6 78.4b 80.6
Total (bases 735 to 3107) 83.2 82.9 83.1 82.9 82.lb
P2 2A (bases 3108 to 3661) 79.6 80.1 81.0 80.7
P3 3DP.1 (bases 6879 to 7415) 84.4 82.1 84.2 82.0
3' noncoding (bases 7416 to 7493) 93.7 85.0 85.3 93.2
a Cleavage points between the PA21 capsid proteins were those proposed by Cohen et al. (5) for HM175 virus.
b Includes 18-base deletion in VP1.
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FIG. 4. Nucleotide and predicted amino acid sequence of the PA21 capsid protein VP1. Numbering and cleavage sites are based on those
of Cohen et al. (5). The differences present in the HM175 sequence are displayed above (nucleotides) or below (amino acids) the PA21
sequence.
Although it has generally been accepted that captive
primates become infected with HAV by transmission of
virus from humans, there are several studies that suggest
that HAV infection may occur naturally among some simian
species in the wild (3, 6, 35). The identification of PA21 virus
in captive owl monkeys in Panama prompted a serologic
analysis of newly captured owl monkeys: 2 of 145 animals
were found to have antibody to HAV (22). Similarly, Burke
and Heisey determined that 18 of 54 cynomolgus monkeys
freshly captured at a remote jungle location had anti-HAV
antibodies (3). The prevalence of antibody among these
animals was correlated with weight and thus age, indicating
infection in the wild. Others have also found evidence of
infection with HAV in recently captured primates (6, 35).
Although the possibility that PA21 was acquired from
humans either recently or in the distant past cannot be ruled
out with complete certainty, the substantial differences
between PA21 and multiple human strains of HAV strongly
suggest that this strain is native to the owl monkey. At the
nucleotide level, PA21 is almost twice as different from the
human strains as they are from each other. To further assess
these differences, the University of Wisconsin Genetics
Computer Group Sequence Analysis Software Package DIS-
TANCES program (10) was used to assign quantitative
measures of the distances between the HAV strains. The
HAV strains can be placed into two major groups: LA,
HAS15, CR326, HM175, and MBB (the human isolates) and
PA21 (Fig. 6). The human strains can be further divided into
two groups. Those that are the most closely related geneti-
cally (LA, HAS15, and CR326) are also the most closely
related geographically, their origins being California, Ari-
zona, and Costa Rica, respectively. The other pair, MBB
and HM175, originate from geographically distant areas
(North Africa and Australia, respectively) but have identical
amino acid sequences. The most striking finding in this
analysis, however, is the distance of PA21 from all other
strains, even though it was recovered relatively close geo-
graphically to members of the LA-HAS15-CR326 group.
A similar analysis was carried out at the 3' end of the viral
genome, adding the recently reported sequence of a strain
isolated from an old-world cynomolgus monkey (1). The
nucleotide sequences of the 3' 1,251 bases of the RNA of this
TABLE 2. Percent amino acid identities between capsid proteins
of HAV strains
% Amino acid identity to protein of:
Virus Protein
HM175 LA MBB CR326 HAS15 MS1
PA-21 VP4 100.0 95.7 100.0 95.7 95.7
VP2 97.7 98.2 97.7 96.4 98.2
VP3 98.4 98.0 98.4 98.0 98.0
VP1 95.3 95.3 95.3 95.0 93.3 94.3
Total P1 97.1 97.0 97.1 96.3 96.2a
HM175 VP4 95.7 100.0 95.7
VP2 99.1 100.0 97.3 99.1
VP3 99.6 100.0 99.6 99.6
VP1 99.3 100.0 99.0 97.Oa 98.3
Total P1 99.2 100.0 98.6 98.3a
LA Total P1 99.2 99.1 99.Oa
MBB Total P1 98.6 98.3a
CR326 Total P1 98.2a
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FIG. 5. Amino acid differences between individual HAV strains
and the consensus human virus sequence in the capsid region. The
consensus sequence at each position was determined by the amino
acid present in the majority of the human HAV strains. Each
sequence is represented by a horizontal line, with regions encoding
capsid proteins marked below this line. Positions where the encoded
amino acid differs from the consensus sequence are shown by marks
above the line.
strain (CYNO55) and PA21 virus are equivalently distant
from HM175 (results not shown). The relationship between
the human strains and PA21 in the 3' region is similar to that
found with the P1 region (Fig. 6), but the CYNO55 strain is
as different from PA21 as each simian virus is from the
human strains. This suggests that there may be several
genetically distinct types of HAV, each unique to a different
primate species, a concept that is new to the field of hepatitis
A.
Rico-Hesse et al. (31) have defined "genotypes" of polio-
virus as groups of poliovirus isolates that differ at the
nucleotide level by less than 15%. While arbitrary, this
criterion has allowed useful distinctions to be made between
geographically diverse isolates of poliovirus. According to
this definition, all human HAV strains comprise a single
HAV genotype, while the primate PA21 and CYNO55 iso-
lates represent unique genotypes of HAV. It is notable that
there are multiple genotypes among individual serotypes of
poliovirus currently in circulation worldwide. A similar
degree of genetic diversity is not seen among geographically
diverse isolates of human HAV, although the reason for this
distinction is not apparent at present. On the basis of limited
genomic sequencing of the VP1-2A region, the poliovirus
serotypes have an overall divergence of 29%, while within
poliovirus serotype 1 the maximum divergence is 22.6% (31).
These differences are slightly greater than that found be-
tween the PA21 and human HAV isolates (Table 1).
Differences in the nucleotide sequences of PA21 and
HM175 viruses are randomly distributed throughout the
capsid region, with the exception of a cluster of changes near
the 3' end of the VP1-encoding region. The majority of these
changes (85%) occur in the third base positions of codons,
allowing for continued conservation of the amino acid se-
quence (96.7% average amino acid relatedness to the known
human HAV sequences). In the derived amino acid se-
quence, changes are clustered into three areas: the amino
termini ofVP2 and VP1 and the putative carboxy terminus of
VP1. Although most of these changes are conservative in
nature, the frequency of substitutions within these regions
(particularly at the carboxy terminus of VP1) argues that the
primary structure of these domains is less critical for viral
function or stability than other regions of the capsid pro-
teins. Excluding the replacements evident at the termini of










FIG. 6. Relationship among HAV strains according to the capsid
protein nucleotide sequences. The distance along the horizontal
lines connecting any pair or group of strains to the first common
node denotes the percent nucleotide identity shared by those
strains.
and the consensus human virus capsid protein sequence
(Fig. 5). Four amino acid replacements are scattered
throughout VP3. Two of these are nonconservative, a pro-
line to alanine at 3-040 (residue 40 of capsid protein VP3) and
a glycine to histidine at 3-147. Although VP3 is highly
conserved among human HAV strains and has been shown
to play an important role in the antigenic structure of the
virus (30), it is impossible at this time to determine the
importance of these changes or their relevance to the slight
differences seen in the antigenic structures of PA21 and
human HAVs.
The only difference apparent in a comparison of the
neutralization epitopes of the PA21 and HM175 viruses was
a slightly reduced binding of the B5-B3 monoclonal antibody
to PA21 (Fig. 2). This suggests that at least one of the amino
acid changes found in PA21 is within or near the B5-
B3-binding site. Mutations found by Ping et al. (30) in
neutralization-resistant HAV variants include amino acid
substitutions at residues 3-070, 1-102, and 1-276. Mutations
at 3-070 and 1-102 have each been shown to confer weak
resistance to neutralization with B5-B3, while a mutation at
1-276 has not yet been shown to result by itself in antigenic
changes in the virus. These residues do not correspond to
any specific amino acid replacements found in PA21 virus.
However, multiple changes do surround residue 1-276 in
PA21, including a nonconservative serine-to-aspartic acid
change at 1-277 and an alanine-to-leucine change at 1-281.
Except for the isoleucine-to-valine change at 2-063 (24),
these are the only changes in the PA21 capsid which align
with recognized antigenic sites in other picornaviruses (27),
providing at least indirect evidence for the possible involve-
ment of this region of VP1 in the conformationally defined
antigenic site of HAV.
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